Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2026-05-19 @ 6:04 AM
Study NCT ID:
NCT05429905
Status:
RECRUITING
Last Update Posted:
2023-03-09
First Post:
2021-12-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
Sponsor:
Organization: